Friend and family caregivers of recently deceased cancer patients experience acute
bereavement following the death. Post death bereavement is an intense period of mourning
that includes an unfolding of the grief process and is characterized by strong emotions
and demands on cognitive resources to those who have put aside their own needs to support
the dying patient with cancer. This research will test the feasibility and acceptability
of a nature-based healing meditation (NBHM) intervention to support cancer caregivers'
during the bereavement process.
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06662409.
Locations matching your search criteria
United States
Michigan
East Lansing
Michigan State UniversityStatus: Active
Contact: Rebecca Lehto
Phone: 517-353-4757
Bereaved friend and family caregivers have taken on the burden of end-of-life care for
patients with cancer who die in hospice care at home. Bereavement can be emotionally
devastating, especially to those who have put aside their own needs to support the dying
individual. Supporting bereaved CGs' emotional health and general well-being is a
critical need. The proposed pilot study will evaluate the acceptability and feasibility
of a 6-week low-tech nature meditation intervention aimed at supporting bereaved
caregivers' who are in the first 6 months since the patients' death. The intervention,
based on the mutually supportive role that meditation practices and nature have been
shown to promote wellbeing, will be developed capitalizing on the strengths of the
research team's early intervention work involving patients with advanced cancer and their
caregivers. For this single group longitudinal study, Aim 1 will focus on the development
of 6 nature-based healing meditation (NBHM) auditory modules available via the study
website to facilitate bereavement (grief) recovery and assessed on parameters of directed
attention, grief, and QOL (including parameters of depression/anxiety).
The 2nd aim will then evaluate acceptability and feasibility of the 6-week program of
both content and delivery methods (numbers eligible vs. number consented; numbers
consented vs. numbers completed; number of weeks using the intervention) for the
intervention modules. We will then conduct semi-structured interviews with a small
diverse representative sample of caregivers to evaluate benefits, satisfaction, and
challenges in more depth. Fifty-five home-based cancer caregivers who recently
experienced the death of their patient will be recruited from Hospice of Michigan.
Testing will occur at baseline (Time 1; study week 0), at the intervention end (Time 2;
week 6), and (Time 3; study week 12). This research targets a supportive caregiver
intervention that will be flexibly delivered on-line for use at the caregiver's
convenience. Once feasibility and acceptability for this new intervention to support
bereaved caregivers are addressed, a larger scale randomized control trial will be
sought.
Trial PhaseNo phase specified
Trial Typesupportive care
Lead OrganizationMichigan State University